1. Home
  2. CRIS

CRIS

Curis Inc.

Logo Curis Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 3:33pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Founded: 2000 Country:
United States
United States
Employees: N/A City: LEXINGTON
Market Cap: 91.8M IPO Year: 2000
Target Price: $37.33 AVG Volume (30 days): 36.1K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.96 EPS Growth: N/A
52 Week Low/High: $0.38 - $17.49 Next Earning Date: 05-02-2024
Revenue: $10,023,000 Revenue Growth: -1.37%
Revenue Growth (this year): 5.13% Revenue Growth (next year): 4.12%

Share on Social Networks: